These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 15305342)
1. Molecular analysis of WFDC1/ps20 gene in prostate cancer. Watson JE; Kamkar S; James K; Kowbel D; Andaya A; Paris PL; Simko J; Carroll P; McAlhany S; Rowley D; Collins C Prostate; 2004 Oct; 61(2):192-9. PubMed ID: 15305342 [TBL] [Abstract][Full Text] [Related]
2. Decreased stromal expression and increased epithelial expression of WFDC1/ps20 in prostate cancer is associated with reduced recurrence-free survival. McAlhany SJ; Ayala GE; Frolov A; Ressler SJ; Wheeler TM; Watson JE; Collins C; Rowley DR Prostate; 2004 Oct; 61(2):182-91. PubMed ID: 15305341 [TBL] [Abstract][Full Text] [Related]
3. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model. McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910 [TBL] [Abstract][Full Text] [Related]
4. KLF5 is frequently deleted and down-regulated but rarely mutated in prostate cancer. Chen C; Bhalala HV; Vessella RL; Dong JT Prostate; 2003 May; 55(2):81-8. PubMed ID: 12661032 [TBL] [Abstract][Full Text] [Related]
5. Down-regulation of homeobox gene GBX2 expression inhibits human prostate cancer clonogenic ability and tumorigenicity. Gao AC; Lou W; Isaacs JT Cancer Res; 1998 Apr; 58(7):1391-4. PubMed ID: 9537237 [TBL] [Abstract][Full Text] [Related]
6. Cell specific expression of CD10/neutral endopeptidase 24.11 gene in human prostatic tissue and cells. Song J; Aumüller G; Xiao F; Wilhelm B; Albrecht M Prostate; 2004 Mar; 58(4):394-405. PubMed ID: 14968440 [TBL] [Abstract][Full Text] [Related]
7. Identification of a novel prostate cancer-associated tumor antigen. Miles AK; Rogers A; Li G; Seth R; Powe D; McArdle SE; McCulloch TA; Bishop MC; Rees RC Prostate; 2007 Feb; 67(3):274-87. PubMed ID: 17192878 [TBL] [Abstract][Full Text] [Related]
8. Sprouty4, a suppressor of tumor cell motility, is down regulated by DNA methylation in human prostate cancer. Wang J; Thompson B; Ren C; Ittmann M; Kwabi-Addo B Prostate; 2006 May; 66(6):613-24. PubMed ID: 16388505 [TBL] [Abstract][Full Text] [Related]
9. A novel transcript from the KLKP1 gene is androgen regulated, down-regulated during prostate cancer progression and encodes the first non-serine protease identified from the human kallikrein gene locus. Kaushal A; Myers SA; Dong Y; Lai J; Tan OL; Bui LT; Hunt ML; Digby MR; Samaratunga H; Gardiner RA; Clements JA; Hooper JD Prostate; 2008 Mar; 68(4):381-99. PubMed ID: 18196551 [TBL] [Abstract][Full Text] [Related]
10. Quantitative RT-PCR analysis of estrogen receptor gene expression in laser microdissected prostate cancer tissue. Walton TJ; Li G; McCulloch TA; Seth R; Powe DG; Bishop MC; Rees RC Prostate; 2009 Jun; 69(8):810-9. PubMed ID: 19189301 [TBL] [Abstract][Full Text] [Related]
11. Regional loss of imprinting of the insulin-like growth factor II gene occurs in human prostate tissues. Jarrard DF; Bussemakers MJ; Bova GS; Isaacs WB Clin Cancer Res; 1995 Dec; 1(12):1471-8. PubMed ID: 9815946 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of neuropilin-1 in malignant and benign prostatic stromal tissue. Vanveldhuizen PJ; Zulfiqar M; Banerjee S; Cherian R; Saxena NK; Rabe A; Thrasher JB; Banerjee SK Oncol Rep; 2003; 10(5):1067-71. PubMed ID: 12883660 [TBL] [Abstract][Full Text] [Related]
13. Prostate cancer expression profiling by cDNA sequencing analysis. Huang GM; Ng WL; Farkas J; He L; Liang HA; Gordon D; Yu J; Hood L Genomics; 1999 Jul; 59(2):178-86. PubMed ID: 10409429 [TBL] [Abstract][Full Text] [Related]
14. Expression of two WFDC1/ps20 isoforms in prostate stromal cells induces paracrine apoptosis through regulation of PTGS2/COX-2. Hickman OJ; Smith RA; Dasgupta P; Rao SN; Nayak S; Sreenivasan S; Vyakarnam A; Galustian C Br J Cancer; 2016 May; 114(11):1235-42. PubMed ID: 27115470 [TBL] [Abstract][Full Text] [Related]
15. Mutation analysis and characterization of ATR sequence variants in breast cancer cases from high-risk French Canadian breast/ovarian cancer families. Durocher F; Labrie Y; Soucy P; Sinilnikova O; Labuda D; Bessette P; Chiquette J; Laframboise R; Lépine J; Lespérance B; Ouellette G; Pichette R; Plante M; Tavtigian SV; Simard J BMC Cancer; 2006 Sep; 6():230. PubMed ID: 17010193 [TBL] [Abstract][Full Text] [Related]
16. Human prostatic carcinoma oncogene PTI-1 is expressed in human tumor cell lines and prostate carcinoma patient blood samples. Sun Y; Lin J; Katz AE; Fisher PB Cancer Res; 1997 Jan; 57(1):18-23. PubMed ID: 8988032 [TBL] [Abstract][Full Text] [Related]
17. Analysis of alterations of WFDC1, a new putative tumour suppressor gene, in hepatocellular carcinoma. Saffroy R; Riou P; Soler G; Azoulay D; Emile JF; Debuire B; Lemoine A Eur J Hum Genet; 2002 Apr; 10(4):239-44. PubMed ID: 12032731 [TBL] [Abstract][Full Text] [Related]
18. Integration of high-resolution array comparative genomic hybridization analysis of chromosome 16q with expression array data refines common regions of loss at 16q23-qter and identifies underlying candidate tumor suppressor genes in prostate cancer. Watson JE; Doggett NA; Albertson DG; Andaya A; Chinnaiyan A; van Dekken H; Ginzinger D; Haqq C; James K; Kamkar S; Kowbel D; Pinkel D; Schmitt L; Simko JP; Volik S; Weinberg VK; Paris PL; Collins C Oncogene; 2004 Apr; 23(19):3487-94. PubMed ID: 15007382 [TBL] [Abstract][Full Text] [Related]
19. KLK31P is a novel androgen regulated and transcribed pseudogene of kallikreins that is expressed at lower levels in prostate cancer cells than in normal prostate cells. Lu W; Zhou D; Glusman G; Utleg AG; White JT; Nelson PS; Vasicek TJ; Hood L; Lin B Prostate; 2006 Jun; 66(9):936-44. PubMed ID: 16541416 [TBL] [Abstract][Full Text] [Related]
20. Extensive analysis of the 13q14 region in human prostate tumors: DNA analysis and quantitative expression of genes lying in the interval of deletion. Latil A; Chêne L; Mangin P; Fournier G; Berthon P; Cussenot O Prostate; 2003 Sep; 57(1):39-50. PubMed ID: 12886522 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]